The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl 3-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)carbamoyl]-7-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate ID: ALA5269229
Max Phase: Preclinical
Molecular Formula: C21H20N6O4
Molecular Weight: 420.43
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1cnc2c(C(=O)Nc3c(C)n(C)n(-c4ccccc4)c3=O)cnn2c1C
Standard InChI: InChI=1S/C21H20N6O4/c1-12-15(21(30)31-4)10-22-18-16(11-23-26(12)18)19(28)24-17-13(2)25(3)27(20(17)29)14-8-6-5-7-9-14/h5-11H,1-4H3,(H,24,28)
Standard InChI Key: ZAJUGDTZXLOCPH-UHFFFAOYSA-N
Molfile:
RDKit 2D
31 34 0 0 0 0 0 0 0 0999 V2000
0.3569 -2.4799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0714 -2.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7859 -2.4799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7859 -1.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0714 -1.2424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3569 -1.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4471 -1.4048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9176 -2.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4258 -2.7258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6604 -0.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4569 -0.3949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6703 0.4018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4668 0.6155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5003 1.4565 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7474 1.7417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2303 1.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0499 0.0325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0773 -0.0250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -2.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2145 -2.4800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -3.7169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0714 -3.7171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2145 1.8688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5339 2.5384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4056 1.0939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1170 3.1217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9034 3.9157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1066 4.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5251 3.5501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7339 2.7527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2143 -4.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 2 0
4 3 1 0
5 4 2 0
1 6 1 0
6 5 1 0
6 7 2 0
7 8 1 0
9 8 2 0
1 9 1 0
7 10 1 0
10 11 1 0
11 12 1 0
13 12 2 0
13 14 1 0
14 15 1 0
16 15 1 0
12 16 1 0
13 17 1 0
10 18 2 0
3 19 1 0
20 19 2 0
19 21 1 0
2 22 1 0
14 23 1 0
15 24 1 0
16 25 2 0
26 24 2 0
27 26 1 0
28 27 2 0
29 28 1 0
30 29 2 0
24 30 1 0
21 31 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.43Molecular Weight (Monoisotopic): 420.1546AlogP: 1.87#Rotatable Bonds: 4Polar Surface Area: 112.52Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.95CX Basic pKa: 0.46CX LogP: 0.89CX LogD: 0.89Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.50Np Likeness Score: -1.85
References 1. Hammouda MM, Gaffer HE, Elattar KM.. (2022) Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-a ]pyrimidine scaffold., 13 (10.0): [PMID:36325400 ] [10.1039/d2md00192f ]